SCHEMBL5825112

SCHEMBL5825112

COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)CCC4CCCC4)c(Cl)c3)c2cc1OC

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDGFRA P16234 13/20 0.57
KIT P10721 10/20 0.57
KDR P35968 10/20 0.55
MET P08581 6/20 0.54
FLT1 P17948 4/20 0.54
FLT4 P35916 4/20 0.54
RET P07949 3/20 0.54
PDGFRB P09619 3/20 0.54
FGFR1 P11362 3/20 0.54
RIPK2 O43353 2/20 0.54
STK10 O94804 2/20 0.54
ABL1 P00519 2/20 0.54
BCR P11274 2/20 0.54
SLC6A3 Q01959 2/20 0.54
DDR1 Q08345 2/20 0.54
MAP4K2 Q12851 2/20 0.54
PTK6 Q13882 2/20 0.54
DDR2 Q16832 2/20 0.54
AURKB Q96GD4 2/20 0.54
RIPK3 Q9Y572 2/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5824867 0.91 PDGFRA (0.59) PDGFRAKITKDRMETFGFR2
SCHEMBL1877648 0.88 PDGFRA (0.73) PDGFRAKITKDRMETAURKB
SCHEMBL5825662 0.85 PDGFRA (0.57) PDGFRAKITKDRMETPDGFRB
SCHEMBL1878601 0.82 MET (0.77) PDGFRAKITKDRMETFLT1
SCHEMBL1873985 0.82 PDGFRA (0.60) PDGFRAKITKDRMETFGFR2
SCHEMBL5824684 0.80 MET (0.69) PDGFRAKITKDRMETPDGFRB
SCHEMBL5824606 0.80 PDGFRA (0.66) PDGFRAKITKDRMETFLT1
SCHEMBL2747856 0.80 MET (0.67) PDGFRAKITKDRMETRET
SCHEMBL5824968 0.80 PDGFRA (0.76) PDGFRAKITKDRMETFLT1
SCHEMBL5824708 0.80 PDGFRA (0.65) PDGFRAKITKDRMETFLT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7135466-B2 Quinoline and quinazoline derivatives and drugs containing the same KIRIN BEER KABUSHIKI KAISHA (JP) 2006-11-14 US disclosed
US-20060211717-A1 Quinoline and quinazoline derivatives and drugs containing the same KIRIN BEER KABUSHIKI KAISHA (JP) 2006-09-21 US disclosed
US-20040132727-A1 Quinoline and quinazoline derivatives and drugs containing the same KIRIN HOLDINGS KABUSHIKI KAISHA (JP) 2004-07-08 US disclosed
EP-1243582-A1 QUINOLINE AND QUINAZOLINE DERIVATIVES AND DRUGS CONTAINING THE SAME KIRIN BEER KABUSHIKI KAISHA (JP) 2002-09-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060211717-A1 Quinoline and quinazoline derivatives and drugs containing the same PDGFRA, PDGFRB, PDGFA PDGFRA 1/4885KIT 401/4885KDR 4/4885
US-20040132727-A1 Quinoline and quinazoline derivatives and drugs containing the same PDGFRA, PDGFRB, PDGFA PDGFRA 1/4885KIT 499/4885KDR 5/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.